Literature DB >> 24829851

MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.

Nirav R Shah1, Hexin Chen1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs generated by a two-step complex process and are post transcriptional negative regulators of their target mRNAs. Dysregulation of many of these miRNAs has been associated with tumorigenesis in various cancers including breast cancer. Aberrantly high expression of specific miRNAs in breast cancer cells is demonstrated to be linked with inhibition of tumor suppressor genes and promote tumorigenesis. They are classified as oncogenic miRNAs. However, the tumor suppressor miRNAs are downregulated in breast cancer cells, since their major targets are oncogenic mRNAs. Understanding mechanism of action of specific miRNAs in breast cancer cells can be utilized to develop newer anti-cancer therapies. Recently, newer techniques are also developed to detect abundance of specific miRNA in the blood plasma samples and can be used in early diagnosis or prognosis in breast cancer. In this review article, we have discussed several miRNAs dysregulated in breast cancer and their therapeutic potential.

Entities:  

Keywords:  Breast cancer; Cancer stem cells; Diagnostic markers; Drug resistance; MicroRNAs

Year:  2014        PMID: 24829851      PMCID: PMC4014796          DOI: 10.5306/wjco.v5.i2.48

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  119 in total

Review 1.  The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.

Authors:  Michael M Gottesman; Victor Ling
Journal:  FEBS Lett       Date:  2005-12-28       Impact factor: 4.124

2.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

Authors:  W W Hwang-Verslues; P-H Chang; P-C Wei; C-Y Yang; C-K Huang; W-H Kuo; J-Y Shew; K-J Chang; E Y-H P Lee; W-H Lee
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

4.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

5.  Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.

Authors:  J T Reardon; A Vaisman; S G Chaney; A Sancar
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

6.  MicroRNA-101-mediated Akt activation and estrogen-independent growth.

Authors:  M Sachdeva; H Wu; P Ru; L Hwang; V Trieu; Y-Y Mo
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

7.  Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.

Authors:  Athina Markou; George M Yousef; Efstathios Stathopoulos; Vassilis Georgoulias; Evi Lianidou
Journal:  Clin Chem       Date:  2013-10-16       Impact factor: 8.327

Review 8.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

9.  A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.

Authors:  Yanjie Lu; Jiening Xiao; Huixian Lin; Yunlong Bai; Xiaobin Luo; Zhiguo Wang; Baofeng Yang
Journal:  Nucleic Acids Res       Date:  2009-01-09       Impact factor: 16.971

10.  miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Authors:  Andrea Feliciano; Josep Castellvi; Ana Artero-Castro; Jose A Leal; Cleofé Romagosa; Javier Hernández-Losa; Vicente Peg; Angels Fabra; Francisco Vidal; Hiroshi Kondoh; Santiago Ramón Y Cajal; Matilde E Lleonart
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more
  27 in total

1.  Upregulation of miR-301a correlates with poor prognosis in triple-negative breast cancer.

Authors:  Hong Yu; Hui Li; Hua Qian; Xia Jiao; Xiaowei Zhu; Xiaoqin Jiang; Guihong Dai; Junxing Huang
Journal:  Med Oncol       Date:  2014-10-14       Impact factor: 3.064

2.  Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancer.

Authors:  Vahid Kia; Maryam Sharif Beigli; Vahedeh Hosseini; Ameneh Koochaki; Mahdi Paryan; Samira Mohammadi-Yeganeh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-21       Impact factor: 2.416

3.  miR-141 as potential suppressor of β-catenin in breast cancer.

Authors:  Nairi Abedi; Samira Mohammadi-Yeganeh; Ameneh Koochaki; Fariba Karami; Mahdi Paryan
Journal:  Tumour Biol       Date:  2015-07-13

Review 4.  Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.

Authors:  Anahita Tavakoli; Mohammad Saeed Kahrizi; Kimia Safa; Reza ArefNezhad; Fatemeh Rezaei-Tazangi
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

5.  Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization.

Authors:  Yogin Patel; Ji S Lee; Hexin Chen
Journal:  J Vis Exp       Date:  2016-06-07       Impact factor: 1.355

6.  Topological characteristics of target genes regulated by abiotic-stress-responsible miRNAs in a rice interactome network.

Authors:  Linzhong Zhang; Hongdong Xuan; Yongchun Zuo; Gaojian Xu; Ping Wang; Youhong Song; Shihua Zhang
Journal:  Funct Integr Genomics       Date:  2016-01-30       Impact factor: 3.410

7.  Hypermethylated miR-424 in Colorectal Cancer Subsequently Upregulates VEGF.

Authors:  Zahra Nouri Ghonbalani; Shiva Shahmohamadnejad; Parvin Pasalar; Ehsan Khalili
Journal:  J Gastrointest Cancer       Date:  2021-03-06

8.  MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?

Authors:  Geraldine Cizeron-Clairac; François Lallemand; Sophie Vacher; Rosette Lidereau; Ivan Bieche; Celine Callens
Journal:  BMC Cancer       Date:  2015-07-05       Impact factor: 4.430

9.  MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.

Authors:  Xiaoping Liu; Hailin Tang; Jianping Chen; Cailu Song; Lu Yang; Peng Liu; Neng Wang; Xinhua Xie; Xiaoti Lin; Xiaoming Xie
Journal:  Oncotarget       Date:  2015-08-21

10.  Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.

Authors:  Afshin Taheriazam; Amir Jouya Talaei; Mohammad Jamshidi; Mohammadreza Shakeri; Samaneh Khoshbakht; Emad Yahaghi; Marjan Shokrani
Journal:  Diagn Pathol       Date:  2015-10-07       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.